Key Insights
The South Korean patient monitoring market, valued at $1.07 billion in 2025, is projected to experience robust growth, driven by a rising geriatric population, increasing prevalence of chronic diseases like cardiovascular disorders and diabetes, and expanding healthcare infrastructure. Technological advancements, particularly in remote patient monitoring (RPM) and the adoption of sophisticated devices like multi-parameter monitors and wearable sensors, are significantly contributing to market expansion. Government initiatives promoting telehealth and home healthcare further fuel this growth. The market segmentation reveals a strong demand across various applications, including cardiology, neurology, and respiratory monitoring, with hospitals and clinics representing a major end-user segment. While the high cost of advanced devices and potential data security concerns could act as restraints, the overall market outlook remains positive. The consistent CAGR of 6.87% indicates a sustained upward trajectory, with significant opportunities for market players to capitalize on the growing demand for reliable and advanced patient monitoring solutions.
The forecast period (2025-2033) promises further market maturation, particularly with increasing integration of artificial intelligence (AI) and machine learning (ML) in diagnostic capabilities and predictive analytics. This technological shift will lead to more precise and proactive healthcare, improving patient outcomes and reducing hospital readmission rates. The competitive landscape is dynamic, with established players like Medtronic, Philips, and Abbott competing alongside specialized companies. Strategic partnerships and technological innovations will be crucial for companies to maintain a competitive edge and capture market share in this rapidly evolving sector. Focus on enhancing data security protocols and ensuring user-friendly interfaces for diverse technological literacy levels within the South Korean population will be key to future success.
This comprehensive report offers an in-depth analysis of the South Korea patient monitoring industry, providing valuable insights for stakeholders across the value chain. The study period covers 2019-2033, with 2025 as the base and estimated year, and a forecast period of 2025-2033. The report examines market size, growth drivers, challenges, and future opportunities, supported by robust data and analysis. The total market value in 2025 is estimated at $XX Million, and projected to reach $XX Million by 2033.

South Korea Patient Monitoring Industry Market Composition & Trends
This section analyzes the competitive landscape, innovation drivers, regulatory environment, substitute products, end-user profiles, and mergers & acquisitions (M&A) activities within the South Korean patient monitoring market.
The market is moderately concentrated, with key players such as Edwards Lifesciences Corporation, Dexcom Inc, Abbott Laboratories, Koninklijke Philips N V, General Electric Company (GE Healthcare), OMRON Corporation, Medtronic Plc, Dragerwerk AG & Co KGaA, Nihon Kohden Corporation, and SCHILLER holding significant market share. However, the emergence of innovative startups and technological advancements is fostering a dynamic competitive environment. Market share distribution in 2025 is estimated as follows: Top 5 players hold approximately 60% of the market, with the remaining 40% distributed among smaller players and emerging companies. M&A activity has been moderate, with total deal values in the last five years estimated at $XX Million.
- Market Concentration: Moderately concentrated, with a few major players dominating.
- Innovation Catalysts: Technological advancements in remote patient monitoring (RPM), AI-powered diagnostics, and wearable sensors.
- Regulatory Landscape: Stringent regulations regarding medical device approvals and data privacy, impacting market entry and product development.
- Substitute Products: Limited direct substitutes, but competition from alternative healthcare solutions and telehealth services.
- End-User Profiles: Hospitals and clinics constitute the largest end-user segment, followed by home healthcare.
- M&A Activity: Moderate activity with a focus on technology acquisition and market expansion.

South Korea Patient Monitoring Industry Industry Evolution
The South Korean patient monitoring industry has witnessed significant growth over the historical period (2019-2024), driven primarily by increasing prevalence of chronic diseases, an aging population, and rising healthcare expenditure. The market experienced a Compound Annual Growth Rate (CAGR) of XX% during this period. Technological advancements such as the development of miniaturized, wireless devices, and AI-driven diagnostic tools have further fueled market expansion. Growing adoption of remote patient monitoring solutions is also a key driver, improving patient outcomes and reducing healthcare costs. Consumer demand is shifting towards user-friendly, personalized, and integrated patient monitoring systems. The forecast period (2025-2033) is expected to witness similar growth trends, with the CAGR projected at XX%.
- Growth Trajectories: Strong historical growth with a projected continuation of this trend.
- Technological Advancements: Miniaturization, wireless connectivity, AI integration, and wearable technology are key innovations.
- Shifting Consumer Demands: Preference for user-friendly, personalized, and integrated monitoring systems.
Leading Regions, Countries, or Segments in South Korea Patient Monitoring Industry
The South Korean patient monitoring market is geographically concentrated in urban areas with high population density and advanced healthcare infrastructure. By application, cardiology dominates the market, driven by high prevalence of cardiovascular diseases. Hospitals and clinics remain the primary end-users, leveraging sophisticated monitoring technologies for in-patient care. Among device types, cardiac monitoring devices represent the largest segment, followed by multi-parameter monitors.
- Key Drivers (By Segment):
- Cardiology: High prevalence of cardiovascular diseases, advanced medical infrastructure.
- Hospitals & Clinics: High concentration of patients, sophisticated monitoring requirements.
- Cardiac Monitoring Devices: Established market, high demand for advanced features.
- Dominance Factors: High prevalence of chronic diseases, a robust healthcare infrastructure, and government initiatives supporting healthcare technology adoption contribute significantly to the dominance of certain segments.
South Korea Patient Monitoring Industry Product Innovations
Recent innovations include the introduction of AI-powered diagnostic tools that enhance accuracy and efficiency. Wearable sensors, integrated with smartphone apps, enable continuous monitoring outside hospital settings, improving patient convenience and remote care management. Miniaturization of devices leads to increased comfort and patient acceptance. These advancements improve data analytics and personalized treatment plans. The unique selling proposition of many new devices lies in their ease of use, portability, and integration with existing healthcare IT systems. For example, the clearance of VUNO's Hativ Pro ECG device highlights the growing adoption of AI-powered solutions.
Propelling Factors for South Korea Patient Monitoring Industry Growth
The South Korean patient monitoring market is propelled by several factors. The aging population necessitates increased monitoring, while rising healthcare expenditure enables greater investment in advanced technologies. Government initiatives promoting digital healthcare and telehealth contribute significantly to market expansion. Technological advancements such as AI and IoT are leading to more accurate, efficient, and user-friendly devices. Furthermore, growing awareness of chronic disease management further drives demand.
Obstacles in the South Korea Patient Monitoring Industry Market
Despite the growth potential, the market faces challenges. High regulatory hurdles for medical device approvals and data privacy concerns create barriers to entry and slow down innovation. Supply chain disruptions, particularly for imported components, can impact device availability and pricing. Intense competition among established players and emerging companies also poses a challenge.
Future Opportunities in South Korea Patient Monitoring Industry
Future opportunities lie in the growing adoption of remote patient monitoring (RPM), particularly in home healthcare settings. Integration of AI and IoT technologies will further enhance device capabilities and data analytics. The development of personalized monitoring systems catering to specific patient needs presents significant potential. Expansion into niche applications, like weight management and fitness monitoring, also offers growth opportunities.
Major Players in the South Korea Patient Monitoring Industry Ecosystem
- Edwards Lifesciences Corporation
- Dexcom Inc
- Abbott Laboratories
- Koninklijke Philips N V
- General Electric Company (GE Healthcare)
- OMRON Corporation
- Medtronic Plc
- Dragerwerk AG & Co KGaA
- Nihon Kohden Corporation
- SCHILLER
Key Developments in South Korea Patient Monitoring Industry Industry
- August 2022: The South Korean Ministry of Food and Drug Safety granted clearance to VUNO for its Hativ Pro ECG device, a portable device utilizing a connected mobile app. This signifies growing acceptance of AI-powered diagnostics.
- August 2022: Researchers at KAIST developed an electronic tattoo ink functioning as a bioelectrode. This innovation could lead to more comfortable and unobtrusive patient monitoring.
Strategic South Korea Patient Monitoring Industry Market Forecast
The South Korean patient monitoring market exhibits strong growth potential driven by technological advancements, rising healthcare expenditure, and an aging population. The forecast period (2025-2033) is expected to witness continued expansion, with opportunities arising from the growing adoption of remote patient monitoring, AI integration, and personalized healthcare solutions. The market is poised for sustained growth, offering significant returns for players capable of navigating regulatory landscapes and embracing technological advancements.
South Korea Patient Monitoring Industry Segmentation
-
1. Type of Device
- 1.1. Hemodynamic Monitoring Devices
- 1.2. Neuromonitoring Devices
- 1.3. Cardiac Monitoring Devices
- 1.4. Multi-parameter Monitors
- 1.5. Respiratory Monitoring Devices
- 1.6. Remote Patient Monitoring Devices
- 1.7. Other Types of Devices
-
2. Application
- 2.1. Cardiology
- 2.2. Neurology
- 2.3. Respiratory
- 2.4. Fetal and Neonatal
- 2.5. Weight Management and Fitness Monitoring
- 2.6. Other Applications
-
3. End Users
- 3.1. Home Healthcare
- 3.2. Hospitals and Clinics
- 3.3. Other End Users
South Korea Patient Monitoring Industry Segmentation By Geography
- 1. South Korea

South Korea Patient Monitoring Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6.87% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Burden of Chronic Diseases due to Lifestyle Changes; Growing Preference for Home and Remote Monitoring
- 3.3. Market Restrains
- 3.3.1. High Cost of Technology
- 3.4. Market Trends
- 3.4.1. Remote Patient Monitoring Devices Segment Expects to Register a High CAGR in the South Korea Patient Monitoring Market Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. South Korea Patient Monitoring Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type of Device
- 5.1.1. Hemodynamic Monitoring Devices
- 5.1.2. Neuromonitoring Devices
- 5.1.3. Cardiac Monitoring Devices
- 5.1.4. Multi-parameter Monitors
- 5.1.5. Respiratory Monitoring Devices
- 5.1.6. Remote Patient Monitoring Devices
- 5.1.7. Other Types of Devices
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Cardiology
- 5.2.2. Neurology
- 5.2.3. Respiratory
- 5.2.4. Fetal and Neonatal
- 5.2.5. Weight Management and Fitness Monitoring
- 5.2.6. Other Applications
- 5.3. Market Analysis, Insights and Forecast - by End Users
- 5.3.1. Home Healthcare
- 5.3.2. Hospitals and Clinics
- 5.3.3. Other End Users
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. South Korea
- 5.1. Market Analysis, Insights and Forecast - by Type of Device
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Edwards Lifesciences Corporation
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Dexcom Inc
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Abbott Laboratories
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Koninklijke Philips N V
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 General Electric Company (GE Healthcare)
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 OMRON Corporation
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Medtronic Plc
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Dragerwerk AG & Co KGaA
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Nihon Kohden Corporation
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 SCHILLER*List Not Exhaustive
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.1 Edwards Lifesciences Corporation
List of Figures
- Figure 1: South Korea Patient Monitoring Industry Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: South Korea Patient Monitoring Industry Share (%) by Company 2024
List of Tables
- Table 1: South Korea Patient Monitoring Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: South Korea Patient Monitoring Industry Revenue Million Forecast, by Type of Device 2019 & 2032
- Table 3: South Korea Patient Monitoring Industry Revenue Million Forecast, by Application 2019 & 2032
- Table 4: South Korea Patient Monitoring Industry Revenue Million Forecast, by End Users 2019 & 2032
- Table 5: South Korea Patient Monitoring Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 6: South Korea Patient Monitoring Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 7: South Korea Patient Monitoring Industry Revenue Million Forecast, by Type of Device 2019 & 2032
- Table 8: South Korea Patient Monitoring Industry Revenue Million Forecast, by Application 2019 & 2032
- Table 9: South Korea Patient Monitoring Industry Revenue Million Forecast, by End Users 2019 & 2032
- Table 10: South Korea Patient Monitoring Industry Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the South Korea Patient Monitoring Industry?
The projected CAGR is approximately 6.87%.
2. Which companies are prominent players in the South Korea Patient Monitoring Industry?
Key companies in the market include Edwards Lifesciences Corporation, Dexcom Inc, Abbott Laboratories, Koninklijke Philips N V, General Electric Company (GE Healthcare), OMRON Corporation, Medtronic Plc, Dragerwerk AG & Co KGaA, Nihon Kohden Corporation, SCHILLER*List Not Exhaustive.
3. What are the main segments of the South Korea Patient Monitoring Industry?
The market segments include Type of Device, Application, End Users.
4. Can you provide details about the market size?
The market size is estimated to be USD 1.07 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Burden of Chronic Diseases due to Lifestyle Changes; Growing Preference for Home and Remote Monitoring.
6. What are the notable trends driving market growth?
Remote Patient Monitoring Devices Segment Expects to Register a High CAGR in the South Korea Patient Monitoring Market Over the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost of Technology.
8. Can you provide examples of recent developments in the market?
In August 2022, the South Korean Ministry of Food and Drug Safety granted clearance to VUNO, a medical artificial intelligence company, for its ECG device, Hativ Pro, a portable medical device that measures a user's heart rate and sends this data through a connected mobile phone app.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "South Korea Patient Monitoring Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the South Korea Patient Monitoring Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the South Korea Patient Monitoring Industry?
To stay informed about further developments, trends, and reports in the South Korea Patient Monitoring Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence